Politico May 1, 2024
Erin Schumaker, Daniel Payne, Carmen Paun and Ruth Reader

Social workers are prepping for the psychedelic revolution.

The Food and Drug Administration has set a target date of Aug. 11 for a decision on the first drug application for talk therapy combined with MDMA, commonly called ecstasy, as a treatment for post-traumatic stress disorder. Should the FDA approve Lykos Therapeutics’ application, universities that train social workers, psychologists and psychiatrists want to be ready.

The Columbia University School of Social Work is rolling out a 25-person psychedelic-assisted training program this fall, which includes 120 hours of classroom coursework and 600 hours of clinical experience in a ketamine clinic.

Unlike independent training programs, which can run thousands of dollars per course, Columbia isn’t charging its masters’ students extra, said Heidi Allen,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Patient / Consumer, Provider
Behavioral health needs better metrics — Centerstone steps up
Wellpath's behavioral health unit becomes independent company
1 system's 'no wrong door' strategy for behavioral health
Prisma Health opens $3.7 million behavioral health facility
‘Not For the Faint of Heart’: What Makes (or Breaks) Mental Health Payer Pilots

Share This Article